Anavex Life Sciences Corporation (AVXL) Options

Expect AVXL to close in the green today with over 1 million shares bought ...also expect great news and a short squeeze this week

Perhaps that's why the closing Ceremonies...Captain obvious?

Month of March
AVXL UP $1 on 6M shares total Volume
MOC included (insert sarcasm)

It is in the largest hall, which can accommodate thousands of people...

Did I read this correctly....
Last Day / Last Time (Dinner) of the entire Conference?
The final 15 minutes should be interesting with filtering in crowd
for closing ceremonies.

Below is what I am watching in terms of price movement and support.

The deeper this market down trend lasts the more difficult it will become for AVXL to maintain current up trend as well as horizontal support.
News trumps charts in isolation. Approval news etc is the booster propellant needed to achieve liftoff and an outer space orbit. There have been successful test flights. Now we can see beyond to the possibilities of realizing putting a payload into space. Is our target the moon, sun or the ever increasing outer limits of deep space?

https://investorshub.advfn.com/uimage/uploads/2025/3/11/byqnvScreen_Shot_2025-03-11_at_8.24.04_AM.png

PS: current days low is 8.60 with current price 8.65.

Thanks for the link.

SAVA's full phase3 rethink results are presented just after us.

CONTINUES TO SIGNIFICANTLY BENEFIT EARLY ALZHEIMER'S DISEASE PATIENTS (ID 3170)
Presenter Timo Grimmer (Germany)
Author Marwan N. Sabbagh (United States of America), William R. Chezem (United States of America), Kun Jin (United States of America),
Juan Carlos Lopez-Talavera (United States of America), Christopher U. Missling (United States of America), Timo Grimmer (Germany)
Lecture Time 18:15 - 18:30
https://cslide.ctimeetingtech.com/adpd25/attendee/confcal/session/calendar?q=blarcamesine

I was just talking to my 96 year old Mom about her lifestyle (similar to your situation) and she recognized how fortunate her Golden Years have been with a house, right sized and paid off years ago, and living off a pension that has an annually increasing benefit. The only down side of course is my Dad passed at 92, but his memory is still thankfully fresh in her very good memory. 

Thinking this is relevant is akin to recalling Anavex in 2004..

News on a partner could be announced any day now.
The big boys are trying to get in cheap , but our CEO is very confident in his number and will not budge . He told Tom Bishop he was looking out for the shareholders, and he is.
Look for news very soon !!!’
Booooom !!!

Good luck and GOD bless,

9 years and counting

An Australian TV news interview of Ern Heaven and his wife. Ern had Alzheimer's for over 2 years and was declining when he joined the Anavex phase 2a trial of Anavex 2-73. Over a period of a year on the drug, he first stabilized, and then improved. No other drug has ever helped an Alzheimer's patient improve.

According to the 1 year trial results, 6 patients out of the initial 32 had "strong" reactions and showed improvements in one or more tests.



Good luck and GOD bless,

The golden age of innovation when it comes to finding therapies for alzheimers is not too far away. Just ask the patients who have been on blarcamesine.

I bought a bunch of april 9 dollar calls for.86 today. I think we hold above 9 bucks soon. 10 dollars is not far off either. Go avxl.

Blarcamesine and 3-71 Will Solve U.S. Deficits

Actually, when blarcamesine, Anavex 3-71, and the other drugs in the Anavex pipeline get approved for all of the anticipated indications, and especially when everyone takes a daily Anavex pill to maintain continuing good health, health care and medical costs will plunge dramatically; so much that our annual federal budget deficits will evaporate. Trillions upon trillions of dollars will be saved.

[Of course, offered to keep things light; a bit of off-putting sarcasm....]

This is the only social media platform I'm on.
Because of Anavex of course.
And all of you who must share your precious opinions on off topic subjects have managed to ruin this too.
Do you not have anywhere else to show off your keen insights?
I'm guessing not.
Do you not wonder why?

Probably so. Like me in retirement I don't make what I did as a working engineer. Retirement income replaced with social security and a pension if your so lucky. I'm one of the luck ones. My wife and I live like my parents did just enjoying life, freezing and canning and going to church. Living frugal. Our carbon foot print is a baby step. lol

Medicare Costs and Blarcamesine
And the cheapest solution potentially available, blacarsamine, [to treat Alzheimer's] will benefit if there was belt-tightening.
As we know, increasing numbers of the elderly are succumbing to Alzheimer's disease each year. They all will need treatment; which in the U.S will involve Medicare or other government funding sources.

The existing Alzheimer's treatments, the FDA-approved monoclonal antibody drugs, Leqembi, etc., are extremely expensive. Blarcamesine won't be. The cost difference will be a powerful driver for blarcamesine approval and utilization; across the Western world. Government medical insurance agencies save lots and lots of money. Patients do, too. And, blarcamesine is far easier and convenient to take, a single pill a day. No need to be taken to a radiology center to get periodic brain scans to check for brain hemorrhaging or shrinkage. Most importantly, blarcamesine will exhibit far better treatment outcomes.

Blarcamesine, and Anavex (and its shareholders) will win.

WGT is talking about Medicare and Anavex—it's like putting the cart before the horse. The moron CEO isn’t even talking to the FDA. He first needs to schedule a Type B meeting with the agency and come up with a plan for NDA filing. Even if he starts today, it will take more than a year for an FDA decision. So lay down your pipe and get back to reality.

Correct. Medicare advantage is not government Medicare. People should avoid these plans which look good up front but provide less at their core.

With "Advantage" plans, the insurer decides if you get treatment. So if you have cancer and are 85, they could say it is not cost-effective to treat you, go die. Kind of like what the original Obamacare was about with Dr. Ezekiel Emmanuel. Death panels doing economics analysis.

Get supplementary medicare insurance where you and the doctor make the decision on treatment, not an economist.

2-73 should be covered by Medicare part D - and part D premiums are based on income. Do you agree?

You ARE kidding about Medicare premium pricing?
Do just a bit of investigating.
Sight unseen I would take your premium.

Incorrect and silly statement

Yes, investors here should keep an eye on the political threat to Medicare and Medicaid, since those are critical insurers in the event of FDA approval of blarcamesine and an ultimate source of a great deal of revenue for us in the U.S. Alzheimer's market.

There is no threat to Medicare, in fact rooting out the fraud and corruption is necessary to protect them. And the cheapest solution potentially available, blacarsamine, will benefit if there was belt-tightening.

AVXL can certainly be a Safe Haven Investment. But it will be affected by the general market. Volumes should be much higher. The share price should already be multiples of the current price!
However there are powerful catalysts in coming months.
1. More long term trial (OLE) information.
2. Anavex 3-71 phase 2b Schizophrenia trial results.
3. Partnerships for Europe, the UK, Canada and Australia and Asia
4. European approval for blarcamesine.
5. FDA discussions leading to priority review.
There is a worldwide need for blarcamesine and Anavex 3-71. That need will only increase with time.
Follow the science!

Medicare premiums are the same for the "less wealthy". Many may not know this but government premiums have risen $30.00 a month for everyone on medicare just to pay the "mab" costs. I'm hoping when Blarcamesine is approved costs will revert back. Hope springs eternal. Praying for a good outcome for medicare folks and everyone else.

Jonjones--"You never know."--long time no hear from you---good to see you are still around--our day coming soon !!!!

Since you are here on a stock message board, you are probably wealthy. But many are not - and that is when the government and insurance steps in. Undermine that system and the upside lowers.

Cool the engines….one day does not a trend make.

AVXL as a Safe Haven Investment?

Ok, how might a typical, general stock investor perceive things when the stock indices all continue to descend, but the AVXL share price continues to ascend?

Stock investors do their D.D., due diligence (which is, really, their "determining diligence"). What will potential new AVXL investors find when they search around for the reasons the AVXL share price is rising, contrary to the declining trends of the stock indices?

Will potential new AVXL buyers see that Anavex science is becoming validated, and large drug sales will begin, especially when the European Medicines Agency approves blarcamesine for Alzheimer's?

Shortly, will Anavex Life Sciences Corp be a safe haven investment in an otherwise declining equity market? Let's watch.

Expect over 1 million AVXL shares to be bought today!!!

Good luck and GOD bless,

Medicare advantage is not government Medicare. People should avoid these plans which look good up front but provide less at their core. Medicare is run much more leanly than for-profit Medicare advantage plans. However, they all would suffer if Medicare is cut, including any coverage of AD prescriptions.

Congress created the Advantage option for Medicare at the behest of the insurance industry to get a chance to make profits from Medicare recipients.
They make profits by minimizing care through procedural run arounds and paperwork.

I ‘m very happy with my regular Medicare since it is not driven by a profit motive.
No run around getting coverage when needed.

Anavex news... like a box of chocolates ... and so on.

How many people expect news regarding Anavex this week???

Good luck and GOD bless,

Cancer indications - yes!

Medicare advantage has been eroding for years now, they are paying less and less while raising the out of pocket and now most want you to get a referral. Jerking old people around is what they do best. Congress needs to kick these insurers in the keester.

“List Price” of Rx for the retired is a fallacy.
However, $10K/yr premiums and 3-5K deductible is a reality per couple.
Factor in Dental and Vision…you best be prepared for retirement.

Of course those able to gamble in pre revenue bio shouldn’t worry…..

Drugs are covered by Part D plans. Every Medicare recipient chooses which plan they want to enroll in. Each plan has different drugs that it will pay for and those are chosen by the private plans.

I like most elderly on medicare pay for our meds. My supplemental prescription plan helps but I still pick up my portion. These plans are not cheap and on top of monthly medicare costs. I don't know anyone getting anything cheap.

Just doing a little AI searching. Companies can and have been approved after clock stop 1.

You never know. 

If approved, then 2-73 will be a winner.

Here is the published scientific article.
https://onlinelibrary.wiley.com/doi/10.1111/acel.13037

Why do you care what I believe? I state my positions on the various Anavex issues. Agree or disagree as you wish. My opinion of the value of other posters is a personal evaluation. I like to keep it that way most of the time. Well, unless there is something so silly I can't help but make fun of it.

The flip side might be…

Hold 300K shares through $30
and back to $3 because AVXL
“has the goods” and WGT. Or one could just take the Sat phone and go fight forest fires.

Not verifying either scenario, but I think I can figure out which has done better.

There is always tomorrow, News, and WAGs about performance. This MB does not lack for assurances.

Yes, investors here should keep an eye on the political threat to Medicare and Medicaid, since those are critical insurers in the event of FDA approval of blarcamesine and an ultimate source of a great deal of revenue for us in the U.S. Alzheimer's market.

The effective and inexpensive will rise to the top in the new environment.

Not entirely true because public companies all share the same macro environment. Self-infliected economic distress impacts all companies. But, yes, Anavex does not sell imported steel or aluminum or lumber or oil etc. And maybe the fact that their CEO is German and is fluent in Italian will be a major asset during the MAA process. In the USA, medicare and medicaid pay for a lot of medications - especially for the elderly - so cutting the legs from under those programs could be a problem for drug companies generally and for Anavex specifically.

pre-revenue bios unaffected by tariff wars.

Approval is not imminent, nor is it certain (although I think it is probable.) Anavex simply is not subject to all of the same market forces that much of the market is.

The next value driver will be OLE presentation (April). Then Clock Stop One info (May-June). Then 3-71 top line readout in July. Maybe Anavex gets a partner, too, at some point (wildcard.)